An 8-year-old male rhesus monkey (Macaca mulatta) died following a 6-day illness consisting of progressive depression, anorexia, labored abdominal breathing, coughing, and tachypnea. Gross necropsy findings included severe multifocal (miliary) granulomatous pneumonia, granulomatous splenitis, and multifocal cerebral abscesses. Histologic examination revealed 10-15-m broad-based budding organisms within pyogranulomatous inflammatory lesions in the lung, tracheobronchial lymph node, brain, spleen, and liver. The distribution of extrapulmonary lesions was intermediate between that described for dogs and that described for humans. These findings were consistent with blastomycosis, which is previously unreported in nonhuman primates.
North American blastomycosis is a systemic fungal disease caused by the dimorphic fungus Blastomyces dermatitidis. Since first described in 1894 in human beings, the disease has been well characterized and documented in many species of animals. 1, 2 The course of the disease is variable, including subclinical infection, self-limiting acute pneumonia, chronic pneumonia, or disseminated disease. 1 The site(s) and frequency of extrapulmonary dissemination vary among species. In human beings, the most common sites for extrapulmonary dissemination (in descending order) are the skin, skeleton, male genitourinary system, and central nervous system. 1, 6 Infrequent sites of dissemination include the liver, spleen, and lymph nodes. 1 In dogs, the most common sites for extrapulmonary dissemination are the lymph nodes, skin, eyes, and skeleton. Less common sites of dissemination are the central nervous system, urogenital tract, and spleen. 7, 8 An 8-year-old male rhesus monkey (Macaca mulatta) presented with mild tachypnea and dyspnea following a lengthy experimental procedure conducted the day before. The procedure involved catheterization of the left ventricle and injection of 80 ϫ 10 6 latex microspheres (diameter 15 Ϯ 0.3 m) for peripheral distribution. The procedure was completed without apparent complication; recovery from anesthesia was uneventful. The next morning and over the following 6 days, depression, anorexia, labored abdominal breathing, and tachypnea were observed. A harsh, productive cough developed on day 4. Despite aggressive supportive therapy, including diuretics, broad-spectrum antibiotics, and analgesics, the monkey's condition deteriorated, culminating in death 6 days after presentation. A complete necropsy was done immediately.
At necropsy the animal appeared in good body condition. There was moderate scrotal and inguinal edema. The lungs were diffusely hyperinflated and did not collapse when the thoracic cavity was opened. The lungs were gray to white and had pleural vascular distension. There was a granular texture throughout with disseminated firm nodules, ranging in diameter from 1 to 5 mm (Fig. 1 ). The right middle lung lobe was firm and dark red. The spleen contained a 1-cmdiameter firm, pale yellow irregular nodule. There was minimal focal gastric ulceration and hemorrhage. The right cerebral frontal lobe and left occipital lobe each had 1-ϫ 2ϫ 2-cm abscesses (Fig. 2) .
Impression smears of the pulmonary, splenic, and cerebral lesions stained with modified Wright's stain revealed pyogranulomatous inflammation and thick-walled, round, 10-15-m fungal organisms consistent with Blastomyces dermatitidis. 5 Examination of formalin-fixed, paraffin-embedded, hematoxylin and eosin (HE)-stained tissues revealed severe, multifocal pyogranulomatous pneumonia ( Fig. 3) , pyogranulomatous tracheobronchial lymphadenitis, focal pyogranulomatous splenitis, and minimal focal granulomatous hepatitis, all containing intralesional fungal organisms consistent with B. dermatitidis. Lesions within the cerebral cortex were multiloculated, cavitated, and expansile, replacing the normal parenchyma. The cerebral lesions consisted of a peripheral zone of macrophages and multinucleated giant cells surrounding a liquefied center filled with neutrophils and necrotic cellular debris. Admixed throughout the lesions, free and within phagocytic cells, were myriads of thick-walled fungal organisms (Fig. 4) . In all lesions, the Brief Communications and Case Reports organisms had similar morphology: round to oval shape, 10-15 m in diameter, with a thick, intensely periodic acid-Schiff (PAS)-positive refractile wall (1-2 m thick), and coarsely clumped basophilic protoplasm. Broad-based single budding was seen occasionally (Fig. 4 ).
Microspheres were found in capillaries within renal glomeruli, myocardium, lung, and lymph nodes; however, no microsphere-associated infarctions or inflammatory responses were observed. Other findings included hepatocellular dissociation, hepatocellular anisokaryosis, binucleate hepatocytes, rare hepatocellular mitoses, hepatic extramedullary hematopoiesis, and gastric and renal hemorrhage.
Aerobic culture of the lung revealed heavy growth of Escherichia coli and no growth of Mycobacterium. Aerobic culture of the cerebral abscess revealed no growth. Fungal culture of frozen lung tissue on Saboraud-dextrose agar was unsuccessful. Serum collected 2 days prior to the monkey's death was submitted for B. dermatitidis titer; the results were 1 : 32, with greater than 1 : 8 considered positive. Antibodies to simian retroviruses (SRV) 1, 2, and 5, simian immunodeficiency viruses (SIVsm, SIVmac, SIVagm), and simian Tcell leukemia virus were not detected. SRV isolation from frozen lymph node was negative. Formalin-fixed, paraffinembedded lung sections were submitted to the Centers for Disease Control (Atlanta, GA) for immunofluorescent detection of B. dermatitidis antigen; the results were equivocal.
Although well characterized in some species, blastomycosis has not been reported previously in nonhuman primates. The acute onset of respiratory signs following the experimental procedure confounded antemortem diagnosis. Also confounding diagnosis were the disease's previously unrecognized status in nonhuman primates and the animal's lack of exposure to soil while at our facility from June 1996 until death in February 1997. While at the Tulane Regional Primate Research Center (TRPRC) in Louisiana from November 1988 until September 1992, the animal was housed outdoors with access to soil. Infection likely occurred during this time, suggesting the incubation period in this animal was greater than 4.5 years. The stress of the lengthy experimental procedure and perhaps injection of the microspheres probably exacerbated a prior subclinical illness.
The histologic appearance of the B. dermatitidis organisms in both HE-and PAS-stained sections of paraffin-embedded lung, tracheobronchial lymph node, brain, spleen, and liver are consistent with published descriptions. 1, 7, 8 This distribution of lesions is similar to both human and canine extrapulmonary dissemination. In human beings, the incidence of central nervous system dissemination ranges from 5% in immunocompetent patients to 40% in immunocompromised patients. 3, 4 In contrast, the incidence of central nervous system involvement in dogs is 1%. 8 The involvement of the reticuloendothelial system (spleen, liver, lymph nodes) is less common in human beings with blastomycosis relative to the involvement seen in dogs. 1, 3, 4, 8 The result of the complement fixation test (serum titer 1 : 32) supports the diagnosis of blastomycosis. Equivocal re-sults obtained from fluorescent antibody stains on paraffinembedded HE-stained lung may have been the result of low numbers of B. dermatitidis cell wall antigens, an interference between the conjugate and the yeast cells in the tissue, or a poor potency conjugate (Dr. L. Kaufman, personal communication).
The extent to which nonhuman primates are infected with B. dermatitidis is presently unknown. Consultation with veterinarians at the TRPRC revealed only one documented case of blastomycosis in a monkey during the past 18 years, suggesting that monkeys have a high level of resistance to B. dermatitidis infection. Serum samples from seven other animals at our facility (all of which originated from TRPRC) revealed B. dermatitidis titers of less than 1 : 8. Despite the rarity of reported clinical B. dermatitidis infection, other animals in endemic areas may be at risk. These findings suggest that animals may develop clinical disease more than 4 years after exposure.
